SCHEMBL25150545

SCHEMBL25150545

CCCCCC(CCCCC)c1ccncc1F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
LOXL2 Q9Y4K0 1/20 0.37
RPS6KA3 P51812 1/20 0.35
LATS1 O95835 1/20 0.33
LATS2 Q9NRM7 1/20 0.33
ICMT O60725 1/20 0.32
CYSLTR2 Q9NS75 1/20 0.32
CYSLTR1 Q9Y271 1/20 0.32
NR1I2 O75469 1/20 0.32
KCNA5 P22460 1/20 0.32
KCNH2 Q12809 1/20 0.32
KDM6B O15054 1/20 0.31
KDM4C Q9H3R0 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
BDKRB2 P30411 1/20 0.31
KDM4E B2RXH2 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23869499 0.98 TDP1 (0.37) TDP1L3MBTL1LOXL2RPS6KA3LATS1
SCHEMBL23219779 0.92 NR1I2 (0.38) TDP1L3MBTL1LOXL2RPS6KA3LATS1
SCHEMBL23219667 0.88 LOXL2 (0.40) TDP1L3MBTL1LOXL2RPS6KA3LATS1
SCHEMBL19176519 0.84 TDP1 (0.36) TDP1L3MBTL1LOXL2RPS6KA3ICMT
SCHEMBL20940090 0.84 RPS6KA3 (0.36) TDP1L3MBTL1LOXL2RPS6KA3LATS1
SCHEMBL24690502 0.83 TDP1 (0.35) TDP1L3MBTL1LOXL2CYSLTR2CYSLTR1
SCHEMBL19003682 0.81 LOXL2 (0.38) LOXL2RPS6KA3LATS1LATS2KDM4E
SCHEMBL20626584 0.81 TDP1 (0.39) TDP1L3MBTL1LATS1LATS2CYSLTR2
SCHEMBL10264269 0.80 LOXL2 (0.42) LOXL2RPS6KA3LATS1LATS2
SCHEMBL22260423 0.80 AOC1 (0.38) TDP1L3MBTL1CYSLTR2CYSLTR1NR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11634425-B2 Pharmaceutical compounds PFIZER INC. (US) 2023-04-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11634425-B2 Pharmaceutical compounds GABRA6, CHRNA6, CNR1 TDP1 4556/4885L3MBTL1 1748/4885LOXL2 3578/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.